Article

Diagnostic and Therapeutic Intervention for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors-associated Cardiotoxicity in Non-small-cell Lung Cancer: A Case Study

2024-01-31

Abstract excerpt

<h4>Introduction: </h4> Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) are the first-line standard of care for patients with advanced non-small-cell lung cancer (NSCLC) harboring EGFR mutations. Rates of serious adverse events are lower with EGFR-TKIs than other drugs. However, some reports have described EGFR-TKI-associated cardiac dysfunction, but the underlying mechanism is currently unc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7d8d8ffe-a951-5507-b6f3-01d21909e503
DOI: 10.22541/au.170667269.90159402/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Diagnostic and Therapeutic Intervention for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors-associated Cardiotoxicity in Non-small-cell Lung Cancer: A Case StudyDOI 10.22541/au.170667269.90159402/v1Read

Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer.Semantic proximity Read

Cardiotoxicity Associated with Targeted Therapies in Lung Cancer: A Retrospective Cohort Study of 2,427 Patients with FAERS Pharmacovigilance ValidationSemantic proximity Read

Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy.Semantic proximity Read

Pulmonary Embolism And Bradycardia in a NSCLC Patient Treated With Crizotinib For a Rare Mutation: A Case ReportSemantic proximity Read

Possible heart failure caused by osimertinib in a lung cancer patient.Semantic proximity Read

Simultaneously evaluating efficacy and cardiotoxicity of EGFR-TKI AC0010 with a novel multifunctional biosensorSemantic proximity Read

Pulmonary embolism and bradycardia in a NSCLC patient treated with crizotinib for a rare mutation.Semantic proximity Read

Cardiovascular events in EGFR-mutation non-small-cell lung cancer patients on osimertinib.Semantic proximity Read

Osimertinib- Cardiac Dysfunction with Prolonged QTc Interval: Case ReportSemantic proximity Read

Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer without Risk Factors of Cardiotoxicity. Possibility of Omitting Cardiac Monitoring during Treatment.Semantic proximity Read

Case Report: Fatal myocarditis after combination of immune checkpoint inhibitor and platinum doublet chemotherapySemantic proximity Read

Osimertinib induced cardiac failure and QT-prolongation in a patient with advanced pulmonary adenocarcinoma.Semantic proximity Read